Study: Herpes May Cause Alzheimer’s; polyDNA Recommends Gene-Eden-VIR Against the Latent Herpes Virus

A new study published in the Journal of Alzheimer’s Disease on September 26, 2013 said that the herpes virus (HSV-1) accelerates the onset of Alzheimer’s Disease (AD) (1). polyDNA recommends helping the immune system target the latent HSV-1.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
genital warts remedy
Antiviral agents targeting HSV-1 might slow AD progression. - The Journal of Alzheimer’s Disease

Rochester, NY (PRWEB) October 01, 2013

Encephalitis (inflammation of the brain) caused by the herpes virus (HSV-1) affects the same region of the brain as Alzheimer’s Disease (AD) (1). Moreover, the herpes virus increases the levels of amyloid plaques (insoluble fibrous proteins), which are the most typical feature of an Alzheimer’s brain (1).

The bad news is that finding an HSV-1 specific antibody in standard lab results tells the doctor that there is “an increased risk of dementia (1).” However, the good news, according to study authors, is that antiviral treatment can help. “Recent data also showed that antivirals reduce the formation of key AD proteins in cell cultures acutely infected with HSV-1 (1).” In addition, “Antiviral agents targeting HSV-1 might slow AD progression (1).”

An article published on April 4, 2011 on ScienceDaily.com explained how the herpes virus attacks the brain. Basically, after infection the virus travels along the nerve to the brain. “Herpes infects mucous membranes, such as the lip or eye, and generates viral particles, these viral particles burst out of the cells of the mucous membrane and enter sensory nerve cells where they travel inside the nerve toward the brain (2).”

Large numbers of infected individuals will go on to develop neurological symptoms.

This is possible since HSV-1 establishes a latent infection. It sets up residence in nerve centers. Specifically, it establishes a latent infection “in human peripheral sensory ganglia” according to a study published in the journal Immunological Reviews in August, 1996 (3). When the latent virus reactivates, neurological conditions may develop.

polyDNA suggests targeting the latent virus with Gene-Eden-VIR, a natural antiviral supplement, before HSV-1 “reactivates” and causes disease.

Gene-Eden-VIR is designed to target the latent herpes virus. A recent post marketing clinical study showed that Gene-Eden-VIR is safe and effective. Up to 70% of those studied reported a decrease in viral symptoms. (4)

Each ingredient of Gene-Eden-VIR was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent form of HSV. (4)

To learn more about Gene-Eden-VIR, visit http://www.gene-eden-kill-virus.com. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1)    http://www.ncbi.nlm.nih.gov/pubmed/24072067
(2)    http://www.sciencedaily.com/releases/2011/04/110404122203.htm
(3)    http://archneur.jamanetwork.com/article.aspx?articleid=795486#ArticleInformation
(4)    http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.